Form 4 for SDGR Schrodinger, Inc.
Accepted 2025-04-15 00:00:00 ET · period of report 2025-04-14 · accession 0001490978-25-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-15 | 2025-04-14 | SDGR | Akinsanya Karen | Pres of R, D, Therapeutics | S - Sale+OE | $25.09 | -16.7K | 15.6K | -52% | -$419.5K |
| DM | 2025-04-15 | 2025-04-14 | SDGR | Akinsanya Karen | Pres of R, D, Therapeutics | M - OptEx | $3.16 | +16.7K | 32.3K | +107% | +$52.8K |
| DM | 2025-04-15 | 2025-04-14 | SDGR | Akinsanya Karen | Pres of R, D, Therapeutics | M - OptEx | $0.00 | -16.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-14 | S | D | 8,378 | $25.11 | 23,970 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (4) of this form 4. (F2) Includes 15,625 unvested RSUs. |
| 2 | Common | Common Stock | 2025-04-14 | M | A | 13,378 | $3.22 | 29,003 | D | — | — | (F2) Includes 15,625 unvested RSUs. |
| 3 | Common | Common Stock | 2025-04-14 | M | A | 3,345 | $2.92 | 32,348 | D | — | — | (F2) Includes 15,625 unvested RSUs. |
| 4 | Common | Common Stock | 2025-04-14 | S | D | 5,000 | $25.11 | 18,970 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (4) of this form 4. (F2) Includes 15,625 unvested RSUs. |
| 5 | Common | Common Stock | 2025-04-14 | S | D | 3,345 | $25.00 | 15,625 | D | — | — | (F2) Includes 15,625 unvested RSUs. |
| 6 | Derivative | Stock Option (right to buy) | 2025-04-14 | M | D | 13,378 | $0.00 | 0 | D | $3.22 · — to 2028-08-03 | 13,378 Common Stock | (F5) The option was granted on August 3, 2018 and is fully vested. |
| 7 | Derivative | Stock Option (right to buy) | 2025-04-14 | M | D | 3,345 | $0.00 | 0 | D | $2.92 · — to 2027-10-10 | 3,345 Common Stock | (F6) The option was granted on October 10, 2017 and is fully vested. |